腹主动脉瘤腔内修复与开放修复长期结局的系统综述与荟萃分析
该系统综述与荟萃分析比较了腹主动脉瘤腔内修复(EVAR)与开放手术修复(OSR)的长期(5-9年)和极长期(≥10年)全因死亡率、再干预率和二次破裂率。纳入3项随机对照试验和68项观察性研究,共涉及151,092例EVAR和148,692例OSR患者。结果显示EVAR与更高的长期全因死亡率、再干预率和二次破裂率相关;极长期EVAR再干预和二次破裂率更高,但死亡率无差异;近期研究亚组分析显示长期死亡率无差异。
要点
- EVAR长期全因死亡率高于OSR(OR 1.19)。
- EVAR长期再干预风险是OSR的2.12倍。
- EVAR长期二次破裂风险是OSR的4.84倍。
核心结论
- EVAR与OSR相比,长期全因死亡率、再干预率和二次破裂率更高。
- 极长期EVAR再干预率和二次破裂率更高,但死亡率无差异。
- EVAR死亡率随时间改善,近期研究亚组长期死亡率无差异。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase和CENTRAL数据库至2018年5月。
- 纳入比较EVAR与OSR且随访至少5年的研究,共3项随机对照试验和68项观察性研究。
- 共纳入151,092例EVAR患者和148,692例OSR患者。
- 采用随机效应模型计算合并比值比(OR)和95%置信区间(CI)。
主要发现
- 极长期全因死亡率:无差异,基于15项研究(n=48,721)。
临床怎么用
- 临床决策时应考虑EVAR长期再干预和二次破裂风险较高。
- 对EVAR术后患者应进行警惕的长期监测。
- 近期研究显示EVAR死亡率改善,但需结合患者具体情况个体化选择。
局限性
- 纳入研究以观察性研究为主,可能存在混杂偏倚。
- 各结局指标异质性较高(I2最高达96%)。
- 极长期二次破裂分析仅基于1项研究(n=1116)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study synthesized the literature comparing the long-term (5-9 years) and very long-term (≥10 years) all-cause mortality, reintervention, and secondary rupture rates between endovascular aneurysm repair (EVAR) and open surgical repair (OSR) of abdominal aortic aneurysm (AAA). METHODS: MEDLINE, Embase, and CENTRAL databases were searched from inception to May 2018 for studies comparing EVAR to OSR with a minimum follow-up period of 5 years. Study selection, data abstraction, and quality assessment were conducted by two independent reviewers, with a third author resolving discrepancies. Study quality was assessed using the Cochrane and Newcastle-Ottawa scales. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models. Heterogeneity was quantified using the I2 statistic, and publication bias was assessed using funnel plots. RESULTS: Our search yielded 3431 unique articles. Three randomized controlled trials and 68 observational studies comparing 151,092 EVAR to 148,692 OSR patients were included. Inter-rater agreement was excellent at the screening (κ = 0.78) and full-text review (κ = 0.89) stages. Overall, the risk of bias was low to moderate. For long-term outcomes, 54 studies reported all-cause mortality (n = 203,246), 23 reported reintervention (n = 157,151), and 4 reported secondary rupture (n = 150,135). EVAR was associated with higher long-term all-cause mortality (OR, 1.19; 95% CI, 1.06-1.33; P = .003, I2 = 91%), reintervention (OR, 2.12; 95% CI, 1.67-2.69; P < .00001, I2 = 96%), and secondary rupture rates (OR, 4.84; 95% CI, 2.63-8.89; P < .00001, I2 = 92%). For very long-term outcomes, 15 studies reported all-cause mortality (n = 48,721), 9 reported reintervention (n = 7511), and 1 reported secondary rupture (n = 1116). There was no mortality difference between groups, but EVAR was associated with higher reintervention (OR, 2.47; 95% CI, 1.71-3.57; P < .00001, I2 = 84%) and secondary rupture rates (OR, 8.10; 95% CI, 1.01-64.99; P = .05). Subanalysis of more recent studies, with last year of patient recruitment 2010 or after, demonstrated no long-term mortality differences between EVAR and OSR. CONCLUSIONS: EVAR is associated with higher long-term all-cause mortality, reintervention, and secondary rupture rates compared with OSR. In the very long-term, EVAR is also associated with higher reintervention and secondary rupture rates. Notably, EVAR mortality has improved over time. Vigilant long-term surveillance of EVAR patients is recommended.
引用
- Li B, Khan S, Salata K, et al. A systematic review and meta-analysis of the long-term outcomes of endovascular versus open repair of abdominal aortic aneurysm. J Vasc Surg. 2019. PMID: 31147117. doi:10.1016/j.jvs.2019.01.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。